Companies: 10,795·Total market cap: $144.5T

Autolus Therapeutics plc

Autolus Therapeutics plc

AUTLNASDAQHealthcare● Active

$1.49

$-0.05(-2.94%)

Market Cap$395222751

P/E Ratio—

52W High$2.7

52W Low$1.175

Avg Volume1.6M

Open$1.55

Beta2.01

Net Income Financials Revenue

Autolus Therapeutics plc (AUTL) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

AUTL · net income · updated Jun 8, 2026

Core profitability metrics

AUTL · net income · margin · TTM · CAGR

Net income was −$288.2M for FY2025 (fiscal year ending 2025-12-31), down 30.6% year-over-year. Net profit margin was -381.4%.

FY2025 Net Income−$288.2M▼ -30.6% YoY

Trailing 12M (TTM)−$288.8Mtrailing 4 quarters sum

Net Profit Margin-381.4%−$288.2M ÷ $75.6M

YoY Change-30.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · AUTL net income history · AUTL profit margin

Annual net income data

AUTL · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$288.2M▼ 30.6%-381.4%$75.6M

FY2024Loss−$220.7M▼ 5.9%-2180.4%$10.1M

FY2023Loss−$208.4M▼ 40.0%-12272.3%$1.7M

FY2022Loss−$148.8M▼ 4.7%-2402.9%$6.2M

FY2021Loss−$142.1M▲ +0.0%-9429.1%$1.5M

Net income vs peers (Healthcare)

AUTL vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Autolus Therapeutics plcYOU

AUTL

−$288.2M-30.6%-381.4%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Autolus Therapeutics plc (AUTL) reported net income of −$288.2M for FY2025 (fiscal year ending 2025-12-31), down 30.6% year-over-year. The net profit margin was -381.4% — meaning the company kept $-3.81 of every dollar of revenue as profit.

Autolus Therapeutics plc has not yet achieved annual profitability based on available data (11 fiscal years). The company has reported net losses across all available periods.

Autolus Therapeutics plc's net profit margin was -381.4% for FY2025, based on the latest annual results.

Investors sometimes search for "Autolus Therapeutics plc net worth" — the company's market capitalization is a separate figure from AUTL net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

AUTL net income · 4 questions

Autolus Therapeutics plc is not currently profitable on an annual basis. The company reported a net loss of $288.2M for FY2025.

is AUTL profitabledoes AUTL make a profitAUTL profitabilityAUTL profitable company

▸ Source: FMP /income-statement · GAAP · Autolus Therapeutics plc · Autolus Therapeutics plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026